Lexeo Therapeutics, Inc. (LXEO) › Shares OutstandingLexeo Therapeutics, Inc. (LXEO) — Shares OutstandingAnnual figures by period end, from SEC filings.2022-12-31: 1.61M2023-12-31: 26.65M2024-12-31: 33.07M2025-12-31: 73.00M73.00M2022-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3173.00M+120.7%2026-03-30Balance as of period end2024-12-3133.07M+24.1%2026-03-30Balance as of period end2023-12-3126.65M+1558.0%2025-03-24Balance as of period end2022-12-311.61M—2024-03-11Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)